We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.86%
2 Healthcare 3.34%
3 Consumer Discretionary 2.41%
4 Financials 2.35%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLNG icon
12451
CALL
Dynagas LNG Partners
DLNG
$141M
$85K ﹤0.01%
+29,800
New +$84.6K
ERNA icon
12452
Eterna Therapeutics
ERNA
$4.88M
$85K ﹤0.01%
3
+2
+200% +$108K
HLIT icon
12453
CALL
Harmonic Inc
HLIT
$1.51B
$85K ﹤0.01%
10,800
-10,700
-50% -$84.7K
KMDA icon
12454
Kamada
KMDA
$435M
$85K ﹤0.01%
+13,773
New +$91.2K
OPTT icon
12455
PUT
Ocean Power Technologies
OPTT
$55.6M
$85K ﹤0.01%
+25,600
New +$98.5K
RMTI icon
12456
CALL
Rockwell Medical
RMTI
$29.6M
$85K ﹤0.01%
670
+365
+120% +$54K
SGRP
12457
DELISTED
SPAR Group
SGRP
$85K ﹤0.01%
50,489
+36,581
+263% +$56.1K
TUSK icon
12458
CALL
Mammoth Energy Services
TUSK
$160M
$85K ﹤0.01%
+15,900
New +$80.4K
ORGS
12459
DELISTED
Orgenesis Inc. Common Stock
ORGS
$85K ﹤0.01%
+1,484
New +$96.7K
KIN
12460
PUT
DELISTED
Kindred Biosciences, Inc.
KIN
$85K ﹤0.01%
+17,100
New +$82.6K
IID
12461
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$85K ﹤0.01%
+15,272
New +$80.4K
LEXX icon
12462
Lexaria Bioscience
LEXX
$14.3M
$84K ﹤0.01%
+994
New +$87.4K
PRPH
12463
CALL
DELISTED
ProPhase Labs
PRPH
$84K ﹤0.01%
+1,130
New +$108K
TRIB
12464
CALL
Trinity Biotech
TRIB
$8.07M
$84K ﹤0.01%
149
+35
+31% +$25.2K
GSQD.WS
12465
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$84K ﹤0.01%
+87,437
New +$91.2K
CCRC
12466
DELISTED
China Customer Relations Centers, Inc
CCRC
$84K ﹤0.01%
+13,805
New +$65.9K
RHE
12467
DELISTED
Regional Health Properties, Inc.
RHE
$84K ﹤0.01%
+18,250
New +$97.2K
EVOK
12468
CALL
DELISTED
Evoke Pharma
EVOK
$83K ﹤0.01%
317
-249
-44% -$99.6K
FTK icon
12469
Flotek Industries
FTK
$1.29B
$83K ﹤0.01%
8,248
+3,137
+61% +$39K
LSTA icon
12470
Lisata Therapeutics
LSTA
$10.4M
$83K ﹤0.01%
2,881
-2,299
-44% -$69.7K
NERV icon
12471
PUT
Minerva Neurosciences
NERV
$214M
$83K ﹤0.01%
3,563
-3,050
-46% -$76.2K
STGW icon
12472
PUT
Stagwell
STGW
$2.26B
$83K ﹤0.01%
26,600
+16,000
+151% +$48.7K
TGS icon
12473
PUT
Transportadora de Gas del Sur
TGS
$4.21B
$83K ﹤0.01%
+17,200
New +$85.3K
SIOX
12474
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$83K ﹤0.01%
31,692
-36,739
-54% -$104K
BIOR
12475
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$83K ﹤0.01%
+70
New +$96.5K

Similar funds

Ken Griffin's Q1 2021 Portfolio in Review

As of Q1 2021, Ken Griffin held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Ken Griffin added most to Amazon in Q1 2021, an estimated $627M increase.
  • Ken Griffin's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Ken Griffin fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Ken Griffin's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Ken Griffin opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Ken Griffin's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.